Principles of management of the more common metabolic disorders

Current Paediatrics

Volumn 12, Issue 2, 2002, Pages 117-124

  Chakrapani, A ^a   Wraith, J E ^b  

^a BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^b ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Metabolic diseases; Treatment

Indexed keywords

ALPHA TOCOPHEROL; ANTICONVULSIVE AGENT; ASCORBIC ACID; BICARBONATE; CARNITINE; CARRIER PROTEIN; CYCLOHEXANE DERIVATIVE; DEXTROMETHORPHAN; DICHLOROACETIC ACID; IDEBENONE; KETAMINE; MENADIONE; METHYLENE BLUE; MIGLUSTAT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; RIBOFLAVIN; SCAVENGER; THIAMINE; UBIDECARENONE;

AMINO ACID METABOLISM; BONE MARROW TRANSPLANTATION; CONFERENCE PAPER; DETOXIFICATION; DIET SUPPLEMENTATION; DISORDERS OF PEROXISOMAL FUNCTIONS; EMERGENCY TREATMENT; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME REPLACEMENT; GENE THERAPY; GLYCOGEN STORAGE DISEASE; INBORN ERROR OF METABOLISM; LACTIC ACIDOSIS; LIVER TRANSPLANTATION; LYSOSOME STORAGE DISEASE;

EID: 0036187883     PISSN: 09575839     EISSN: None     Source Type: Journal    
DOI: 10.1054/cupe.2001.0262     Document Type: Conference Paper

References (24)

1. Alternative pathway therapy for urea cycle disorders: Twenty years later
2. Urinary excretion of I-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: Evidence of secondary insufficiency of I-carnitine
3. Tyrosinaemia type I and NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione)
4. Long-term use of high-dose benzoate and dextromethorphan for the treatment of nonketotic hyperglycinemia
5. Emergency treatments
6. Continuous venovenous haemofiltration in the acute treatment of inborn errors of metabolism
7. Liver and kidney transplantation in the treatment of primary hyperoxaluria
8. The management of organic acidaemias: The role of transplantation
9. Type I glycogen storage disease: Five years of management with nocturnal intragastric feeding
10. Type I glycogen storage disease: Nine years of management with cornstarch
11. Disorders of mitochondrial fatty acyl-CoA beta-oxidation
12. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children
13. Disorders of pyruvate carboxylase and the pyruvate dehydrogenase complex
14. Treatment of congenital lactic acidosis with dichloroacetate
15. Mitochondrial encephalomyopathies: What next?
16. 31P NMR study of improvement in oxidative phosphorylation by vitamins K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle
17. Advances in the treatment of lysosomal disorders
18. Bone marrow transplantation for genetic diseases
19. Novel oral treatment of Gaucher's disease with N-butyldeoxynojirmycin (OGT 918) to decrease substrate biosynthesis
20. Gene therapy - A loss of innocence
21. Clinical diagnosis and therapy of peroxisomal disorders
22. X-linked adrenoleukodystrophy: Overview and prognosis as a function of age and brain magnetic resonance imaging abnormality. A study involving 372 patients
23. Gene redundancy and pharmacological gene therapy: Implications for X-linked adrenoleukodystrophy
24. Pharmacological induction of peroxisomes in peroxisome biogenesis disorders